Copart, Inc. (NASDAQ: CPRT), a leading online vehicle auction and remarketing services provider, finds itself at a critical juncture. The stock currently trades at $27.71, hovering just above its 52-week low of $27.29, a stark contrast to its 52-week high of $50.11. This significant decline, a 46.6% drop over the past year, has investors questioning the company's trajectory. Adding to the uncertainty, Director Daniel J. Englander recently executed a substantial open-market sale, disposing of 80,000 shares on July 13, 2026, for a total of $2,204,000 at an average price of $27.55 per share.
This latest transaction is not an isolated event but rather the continuation of a pattern for Englander, who has sold a total of 852,180 shares of CPRT stock since 2021, amounting to an estimated $42.1 million. The timing of such a significant insider sale, especially as the stock languishes near its annual lows, naturally raises questions about management's confidence in the company's near-term prospects. While insider sales can stem from various personal financial planning needs, a consistent pattern of large dispositions, particularly when the stock is under pressure, often warrants closer scrutiny from investors.
Daniel Englander's recent sale is part of a broader trend of insider selling at Copart. His transactions over the past few years paint a clear picture of reducing exposure to the company. Beyond the July 2026 sale, Englander also sold 320,000 shares on January 3, 2025, for approximately $18.21 million at an average price of $56.91 per share. Another significant disposition occurred on January 3, 2024, when he sold 320,000 shares for $16.64 million at an average price of $30.91. Following these transactions, Englander's direct ownership in Copart has been substantially reduced, with QuiverQuant estimating he now owns 100,000 shares, valued at approximately $2.8 million.
This pattern extends beyond a single director. According to MarketBeat, Copart insiders have sold a total of 1,278,774 shares in the last 24 months, amounting to over $69.47 million, with no insider purchases reported during the same period. In the last 12 months alone, insider selling totaled $18.87 million. This imbalance between selling and buying activity is a notable signal. As legendary investor Peter Lynch famously stated, "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise." The absence of insider buying, coupled with persistent selling, suggests that those closest to the company may not see significant upside from current levels.
Despite the bearish signal from insider selling and the stock's poor performance, Copart's recent financial results present a more nuanced picture. The company reported mixed results for Q2 and Q3 fiscal year 2026, demonstrating both challenges and resilience.
Copart Financial Highlights (USD)
| Metric | Q2 FY2026 (Ended Jan 31, 2026) | Q3 FY2026 (Ended Apr 30, 2026) | 6 Months FY2026 (Ended Jan 31, 2026) |
|---|---|---|---|
| Revenue | $1.12 billion (down 3.6% YoY) | $1.24 billion (up 2.1% YoY) | $2.28 billion (down 1.4% YoY) |
| Net Income | $350.7 million (down 9.5% YoY) | $402.4 million | $754.4 million (up 0.7% YoY) |
| Diluted EPS | $0.36 (down 10% YoY from $0.40) | $0.43 (vs Est. $0.41) | $0.77 (flat YoY) |
| Gross Profit | $492.8 million (down 6.2%) | $572.6 million (up 3.7%) | N/A |
| Gross Margin | N/A | 46.3% (up 71 bps) | N/A |
| Operating Income | $388.7 million (down 8.8%) | $464.3 million (up 2.8%) | N/A |
| Operating Cash Flow | N/A | N/A | $662.8 million |
| Cash & Equivalents | N/A | N/A | $5.10 billion |
Note: YoY comparisons for Q2 and 6 Months FY2026 are against the prior year period.
Q2 fiscal 2026, reported on February 19, 2026, showed a softer performance, with revenue declining 3.6% year-over-year to $1.12 billion and diluted EPS falling 10% to $0.36. An Equity Earnings Analyst noted at the time that "Quarterly profit metrics softened, but cash generation and balance sheet strength remained solid." This sentiment was echoed in the StockTitan summary, which highlighted that "Copart posted a weaker quarter, with revenue down 3.6% and net income attributable to the company down 9.5%."
However, the subsequent Q3 fiscal 2026 results, reported on May 21, 2026, offered a rebound. Revenue increased 2.1% year-over-year to $1.24 billion, and diluted EPS came in at $0.43, beating analyst estimates of $0.41. Global gross profit rose 3.7% to $572.6 million, and the gross margin expanded by 71 basis points to 46.3%. This improvement suggests that some of the headwinds faced in Q2 may be temporary, and the company's core business remains robust.
Despite the fluctuations in quarterly performance and the insider selling, Copart's balance sheet remains exceptionally strong, providing a significant buffer against market volatility and operational challenges. As of January 31, 2026, the company reported cash, cash equivalents, and restricted cash totaling $5.10 billion. This substantial cash pile was supported by strong operating cash flow of $662.8 million for the first six months of fiscal 2026.
Beyond its cash reserves, Copart boasts an impressive $6.4 billion in liquidity and virtually no debt, as highlighted by Kavout in April 2026. This financial fortitude allows the company considerable flexibility for strategic investments, market expansion, or weathering economic downturns. For instance, Copart repurchased $218.2 million of common stock during the six months ended January 31, 2026, demonstrating a commitment to returning capital to shareholders even while maintaining a healthy cash balance. This strong financial foundation is a critical factor for long-term investors, suggesting that while the stock price may be volatile, the underlying business is not at risk.
While Copart's balance sheet is a clear strength, the bear case for the stock centers on potential cyclical headwinds and its valuation. The significant 46.6% drop in share price over the past 52 weeks, coupled with the mixed Q2 FY2026 results, has raised concerns about demand durability. Kavout noted that "Recent Q2 FY2026 earnings missed analyst expectations, with revenue down 3.6% year-over-year and EPS declining 10%, raising concerns about demand durability." This softness in unit volumes, particularly in U.S. insurance units, could indicate a more structural issue rather than just temporary factors.
Historically, Copart has traded at a premium valuation. In January 2025, its P/E ratio was 38.7x, and in January 2024, it was 34.10x, both significantly above the industry median. While the current P/E is not explicitly provided, the stock's substantial decline suggests some re-rating has occurred. However, if unit volumes do not stabilize or recover, especially after the "hurricane comparison effect washes out," as Kavout suggested, the stock could face further pressure. The company's reliance on vehicle total loss frequency, while a structural tailwind, can also be subject to short-term fluctuations in accident rates and economic conditions, creating uncertainty for investors focused on near-term growth.
Despite the insider selling and recent stock underperformance, analysts generally maintain a cautiously optimistic outlook for Copart. As of April 24, 2026, the average analyst price target for CPRT stood at $40.50. This target implies a potential upside of approximately 46% from the current trading price of $27.71. However, this average target was set when the stock was trading at $33.07, suggesting that the recent further decline has widened the gap to the consensus.
Analysts are closely monitoring key metrics, particularly U.S. insurance unit growth, excluding direct-buy, to gauge whether the volume softness observed in earlier quarters is indeed temporary. Kavout highlighted that if these unit volumes stabilize or recover, "the stock could see a significant re-rating towards analyst price targets." While the Q3 FY226 earnings beat on revenue and EPS offers some reassurance, the market's reaction, with the stock still near its 52-week low, indicates that skepticism persists. The current valuation, near the low end of analyst targets, suggests that much of the negative news might already be priced in, but a clear catalyst for a sustained rally remains elusive.
Copart presents a classic case of conflicting signals. On one hand, a prominent director has consistently sold shares, including a recent $2.2 million disposition, while the stock has shed nearly half its value over the past year. This insider exodus, coupled with past quarterly revenue dips and ongoing concerns about demand durability, paints a cautious picture. On the other hand, the company's Q3 FY2026 earnings showed a revenue and EPS beat, underpinned by a robust balance sheet featuring $5.10 billion in cash and virtually no debt. This financial strength provides a formidable foundation, suggesting that the underlying business is far from distressed.
For investors, the key lies in discerning whether the insider selling reflects a fundamental deterioration or simply personal portfolio management amidst a challenging market. Given the company's market-leading position and structural tailwinds from rising total loss frequency, the current price may offer an attractive entry point for long-term investors willing to tolerate near-term volatility. However, the lack of insider buying and the significant stock decline warrant a disciplined approach.
Entry Zone: Investors could consider accumulating CPRT shares in the $26.00 to $28.00 range, capitalizing on the current depressed valuation and proximity to the 52-week low. 12-Month Target: A 12-month price target of $38.00 appears achievable, reflecting a partial recovery towards the analyst consensus as volume headwinds potentially abate and the company's strong fundamentals are re-appreciated. Invalidation Level: The thesis would be invalidated if CPRT consistently trades below $25.00, indicating a more severe and persistent deterioration in business fundamentals or market sentiment than currently anticipated.
Copart remains a financially sound company operating in a niche market, but the recent insider activity and stock performance demand a pragmatic approach. The current price offers a compelling risk-reward for those who believe the market has overreacted to temporary challenges and insider dispositions.
Want deeper research on any stock? Try Kavout Pro for AI-powered analysis, smart signals, and more. Already a member? Add credits to run more research.
